Form 4: Elevance Health Executive Felicia F. Norwood Reports Stock Transactions

Felicia F. Norwood, an EVP & President at Elevance Health, reported the acquisition and disposal of company stock and stock options on March 1, 2024.

Summary

• On March 1, 2024, Felicia F. Norwood, an EVP & President at Elevance Health, reported transactions involving Elevance Health's common stock and stock options.
• Norwood disposed of 4,902 shares of common stock to cover tax liabilities at a price of $499.11 per share.
• She also acquired 2,405 restricted share units and 9,152 performance-based restricted share units, both at a price of $0.
• Additionally, Norwood acquired an option to purchase 9,280 shares of common stock at an exercise price of $499.11.
• Following these transactions, Norwood directly owns 40,098 shares of Elevance Health common stock and options to purchase 9,280 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the filing primarily reflects routine stock transactions related to executive compensation and tax obligations. There is no indication of unusual or concerning activity.

Positives

• The acquisition of restricted share units and stock options indicates a continued alignment of Norwood's interests with the long-term performance of Elevance Health.

Future Outlook

The restricted share units vest over a three-year period, and the stock options become exercisable in installments starting one year from the grant date, suggesting a long-term incentive structure.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. They provide insights into the actions of company executives and their confidence in the company's future prospects.

Comparison to Industry Standards

• Executive compensation packages often include a mix of salary, stock options, and restricted stock units to align management's interests with those of shareholders.
• The vesting schedules for restricted stock units and the exercisability of stock options are typical features of executive compensation plans in publicly traded companies like Elevance Health.
• Comparing Norwood's compensation structure and stock ownership to those of executives at similar healthcare companies (e.g., UnitedHealth Group, CVS Health) would provide a broader context for assessing the significance of these transactions.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they primarily involve internal compensation matters.
• Shareholders may view the stock acquisitions as a positive sign of management's confidence in the company.

Key Dates